MedTrace Logo

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

NCT02554240 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2021-04-14

No results posted yet for this study

Summary

This Phase II clinical study is to evaluate the efficacy and safety of DA-5202 in patients with osteoarthritis of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

DA-5202 20mg

once a week, intra-articular injection, for 3 weeks

DRUG

DA-5202 10mg

once a week, intra-articular injection, for 3 weeks

DRUG

Na Hyaluronate 20mg

once a week, intra-articular injection, for 3 weeks

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Myung chul Lee, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-23
Primary Completion
2016-06-29
Completion
2016-10-14

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554240 on ClinicalTrials.gov